Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2020 Summit Therapeutics Inc.(‘Summit’ or the ‘Company’) Cambridge, MA, March 17, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today reports its financial results and provides an update on...

Nephros Reports 2020 Fourth Quarter and Full Year Financial Results Fourth Quarter Net Revenue $2.3 Million, Up 10% Sequentially Over Third QuarterFull Year Revenue $8.6 million, Down 17% Against Prior Year SOUTH ORANGE, NJ, March 01, 2021 (GLOBE NEWSWIRE) -- via...

Final Results Summit Therapeutics plc(‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2019 and Operational...

Notice of Results Summit Therapeutics plc  (‘Summit’ or the ‘Company’) Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2019 Oxford, UK, and Cambridge,...